Skip to main content
Genomictree Inc. logo

Genomictree Inc. — Investor Relations & Filings

Ticker · 228760 ISIN · KR7228760005 KO Professional, scientific and technical activities
Open in API
Filings indexed 237 across all filing types
Latest filing 2019-12-12 Regulatory Filings
Country KR South Korea
Listing KO 228760

About Genomictree Inc.

https://genomictree.com/eng/

Genomictree Inc. is a molecular diagnostics company that develops and commercializes products for the early detection and diagnosis of cancer. The company specializes in epigenomics, utilizing its proprietary genomic-scale discovery tools to identify DNA methylation biomarkers. Its flagship product line, EarlyTect®, offers non-invasive tests for the early screening of colorectal, lung, and bladder cancers. Additionally, Genomictree provides AccuraTect™, a companion diagnostic test for cancer. The company's mission is to improve patient quality of life and reduce medical costs through accessible and accurate early-stage cancer detection.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the suspension of share registration (closing of the shareholder register) for the purpose of determining shareholders for an upcoming Annual General Meeting. It does not contain the full report or meeting materials, but rather serves as a formal regulatory notice of a corporate action. Given it does not fit into specific categories like dividend or share issuance, it falls under the general regulatory filing category.
2019-12-12 Korean
기타경영사항(자율공시)(KRAS 7종 돌연변이 진단제품(AccuraDtect-KRAS) 3등급 체외진단용 의료기기 제조허가 승인)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from a Korean company (Genomictree) regarding a voluntary disclosure of a medical device manufacturing approval. It does not fit into specific categories like financial reports, board changes, or shareholder meetings. As it is a general regulatory announcement regarding business operations and product certification, it falls under the 'Regulatory Filings' category.
2019-12-12 Korean
분기보고서 (2019.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company 'Genomictree' (지노믹트리) for the period ending September 30, 2019. It contains detailed financial information, business descriptions, and management disclosures required for a quarterly filing in the Korean market. It is not an announcement of a report, but the report itself, containing substantive financial data and analysis. 9M 2019
2019-11-14 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 95% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (Corporate Day). It provides details such as the date, time, location, purpose, and contact information for the meeting. Since it is an announcement of an event rather than the presentation materials themselves, and it does not fit into specific categories like earnings releases or financial reports, it is classified as a general regulatory filing.
2019-11-13 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) event (a conference in the US). It provides details such as the date, location, target audience, and purpose of the meeting. It does not contain the actual presentation slides or financial data, but rather serves as a notification of the event. According to the 'Menu vs Meal' rule, since this is a short announcement of an event/presentation rather than the presentation itself, it falls under the category of a regulatory announcement or notice.
2019-11-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when an executive or major shareholder experiences a change in their shareholding status, such as through resignation or trading. This falls under the category of 'Director's Dealing' (DIRS) as it reports the change in ownership status of company insiders.
2019-10-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.